ロード中...
Liposomal Amphotericin B and Leishmaniasis: Dose and Response
Liposomal amphotericin B has been used with increasing frequency to treat visceral leishmaniasis (VL). It is the treatment of choice for immunocompetent patients in the Mediterranean region and the preferred drug for HIV/VL co-infection. Although there is a regional variation in the susceptibility o...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2889656/ https://ncbi.nlm.nih.gov/pubmed/20606972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-777X.62886 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|